Boston-based Akili Interactive Labs has partnered with Delivering Scientific Innovation for Autism (DELSIA), a not-for-profit subsidiary of Autism Speaks. DELSIA is funding an efficacy study of Akili’s iOS-based game, called Project: EVO, with children that have high-functioning autism and ADHD. The trial will be a blind, randomized, placebo-controlled study “that will look to measure cognitive and symptom improvement over one month of device play”, […]
from mobihealthnews http://ift.tt/1EdmQu4
via IFTTT
{ 0 comments }